← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Lovelace Biomedical & Environmental Research Institute
Albuquerque, NM
$161,484,485
Total funding
79
Grants
Funding over time
peak $32.8M · FY2006–22$50M$37.5M$25M$12.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$156,652,599 · 75
CDC$4,831,886 · 4
By mechanism
R01$70,017,621 · 32
N01$58,758,369 · 11
U54$18,440,828 · 10
U01$6,918,228 · 3
R21$3,561,205 · 8
R00$1,259,297 · 2
Investigators at Lovelace Biomedical & Environmental Research Institute
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Largest grants
In Vitro and Animal Models for Emerging Diseases and Biodefense$5,751,575
N01 · FY2008 · AI
Task 19/D21 NHP FOR SARS CORONAVIRUS VACCINE AND DRUG TESTING$5,057,699
N01 · FY2009 · AI
Task 18 (D24): EFFICACY TESTING OF THERAPEUTICS AGAINST ANTHRAX IN NHP$4,342,262
N01 · FY2009 · AI
Identification of Therapeutics for the Treatment of Sulfur Mustard Injury (U54)$3,849,952
U54 · FY2006 · NS
In Vitro and Animal Models for Emerging Diseases and Biodefense$3,716,140
N01 · FY2008 · AI
Identification of Therapeutics for the Treatment of Sulfur Mustard Injury (U54)$3,641,435
U54 · FY2009 · NS
Identification of Therapeutics for the Treatment of Sulfur Mustard Injury (U54)$3,495,553
U54 · FY2008 · NS
Identification of Therapeutics for the Treatment of Sulfur Mustard Injury (U54)$3,451,533
U54 · FY2007 · NS
Identification of Therapeutics for the Treatment of Sulfur Mustard Injury (U54)$3,395,734
U54 · FY2010 · NS
Targeted Clinical Research Program to Address Selected Viral Infections$2,636,719
N01 · FY2011 · AI
Task 17: Antibiotic Efficacy in an AGM Model of Inhalational Yersinia Pestis$2,389,039
N01 · FY2012 · AI
Gene Therapy Resource Program Pharmacology-Toxicology Core Lab$2,000,000
N01 · FY2013 · HL
In Vitro and Animal Models for Emerging Infectious Diseases and Biodefense$1,879,088
N01 · FY2008 · AI
Task C11 NHP Model for Filovirus Vaccine: Efficacy and Immunogenecity Testing$1,769,568
N01 · FY2012 · AI
Task 17 (C31): EFFICACY TESTING OF THERAPEUTICS AGAINST ANTHRAX IN RABBITS$1,719,970
N01 · FY2009 · AI
Task C03 EVALUATION OF THE AEROSOL MONKEYPOX MODEL FOR TESTING ANTIVIRALS$1,626,171
N01 · FY2011 · AI
In Vitro and Animal Models for Emerging Infectious Diseases and Biodefense$1,610,302
N01 · FY2008 · AI
Gene Therapy Resource Program Pharmacology-Toxicology Core Lab$1,524,414
N01 · FY2012 · HL
In Vitro and Animal Models for Emerging Infectious Diseases and Biodefense$1,486,464
N01 · FY2008 · AI
NHLBI GTRP Pharmacology Toxicology Vector Core Laboratory$1,421,024
N01 · FY2008 · HL